Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361818260> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4361818260 abstract "<div>Abstract<p><b>Purpose:</b> Increased frequencies of myeloid-derived suppressor cells (MDSC) correlate with poor prognosis in patients with cancers. Tumor-derived prostaglandin-E2 (PGE2) plays an important role in inducing MDSCs. However, the detailed mechanisms of this induction remain unknown. To develop targeted therapies for MDSCs, we sought to investigate the molecular basis of PGE2-regulated accumulation of MDSCs and their functional consequence on natural killer (NK) cell activity.</p><p><b>Experimental Design:</b> The effects of PGE2 in inducing phenotypic, signaling, and functional alternations on monocytes were analyzed <i>in vitro</i>. Suppression of NK-cell activity by PGE2-treated monocytes was compared with that of freshly isolated CD14<sup>+</sup>HLA-DR<sup>low/−</sup> monocytic MDSCs (moMDSC) from patients with melanoma. In addition, to explore the <i>in vivo</i> relevance of targeting PGE2 to reduce MDSC-mediated suppression of NK cells, we established a murine model, where tumor cells were disabled from cyclooxygenase-2 (COX-2) production.</p><p><b>Results:</b> Patient-derived moMDSCs inhibited NK-cell activity through the production of TGFβ. <i>In vitro</i>, binding of PGE2 to EP2 and EP4 receptors on monocytes activated the p38MAPK/ERK pathway and resulted in elevated secretion of TGFβ. Similar to moMDSCs, PGE2-treated monocytes potently suppressed NK-cell activity through production of TGFβ. Furthermore, silencing COX-2 in murine 4T1 tumor cells reduced the accumulation of CD11b<sup>+</sup>Gr1<sup>+</sup> MDSCs in the spleen, resulting in concomitant improved <i>in vivo</i> clearance of NK-cell sensitive YAC-1 cells.</p><p><b>Conclusions:</b> Our results reveal an indispensable role of tumor-derived PGE2 in inducing MDSCs and suggest a favorable outcome of combining COX-2–targeted therapy and adoptive NK-cell transfer in patients with cancer. <i>Clin Cancer Res; 20(15); 4096–106. ©2014 AACR</i>.</p></div>" @default.
- W4361818260 created "2023-04-05" @default.
- W4361818260 creator A5017053265 @default.
- W4361818260 creator A5028287372 @default.
- W4361818260 creator A5029462216 @default.
- W4361818260 creator A5032423973 @default.
- W4361818260 creator A5063057686 @default.
- W4361818260 creator A5080931838 @default.
- W4361818260 date "2023-03-31" @default.
- W4361818260 modified "2023-10-14" @default.
- W4361818260 title "Data from Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity" @default.
- W4361818260 doi "https://doi.org/10.1158/1078-0432.c.6524766" @default.
- W4361818260 hasPublicationYear "2023" @default.
- W4361818260 type Work @default.
- W4361818260 citedByCount "0" @default.
- W4361818260 crossrefType "posted-content" @default.
- W4361818260 hasAuthorship W4361818260A5017053265 @default.
- W4361818260 hasAuthorship W4361818260A5028287372 @default.
- W4361818260 hasAuthorship W4361818260A5029462216 @default.
- W4361818260 hasAuthorship W4361818260A5032423973 @default.
- W4361818260 hasAuthorship W4361818260A5063057686 @default.
- W4361818260 hasAuthorship W4361818260A5080931838 @default.
- W4361818260 hasConcept C121608353 @default.
- W4361818260 hasConcept C126322002 @default.
- W4361818260 hasConcept C134018914 @default.
- W4361818260 hasConcept C150903083 @default.
- W4361818260 hasConcept C153911025 @default.
- W4361818260 hasConcept C179185449 @default.
- W4361818260 hasConcept C185592680 @default.
- W4361818260 hasConcept C203014093 @default.
- W4361818260 hasConcept C207001950 @default.
- W4361818260 hasConcept C2777198256 @default.
- W4361818260 hasConcept C2777956040 @default.
- W4361818260 hasConcept C502942594 @default.
- W4361818260 hasConcept C55721878 @default.
- W4361818260 hasConcept C71924100 @default.
- W4361818260 hasConcept C86803240 @default.
- W4361818260 hasConceptScore W4361818260C121608353 @default.
- W4361818260 hasConceptScore W4361818260C126322002 @default.
- W4361818260 hasConceptScore W4361818260C134018914 @default.
- W4361818260 hasConceptScore W4361818260C150903083 @default.
- W4361818260 hasConceptScore W4361818260C153911025 @default.
- W4361818260 hasConceptScore W4361818260C179185449 @default.
- W4361818260 hasConceptScore W4361818260C185592680 @default.
- W4361818260 hasConceptScore W4361818260C203014093 @default.
- W4361818260 hasConceptScore W4361818260C207001950 @default.
- W4361818260 hasConceptScore W4361818260C2777198256 @default.
- W4361818260 hasConceptScore W4361818260C2777956040 @default.
- W4361818260 hasConceptScore W4361818260C502942594 @default.
- W4361818260 hasConceptScore W4361818260C55721878 @default.
- W4361818260 hasConceptScore W4361818260C71924100 @default.
- W4361818260 hasConceptScore W4361818260C86803240 @default.
- W4361818260 hasLocation W43618182601 @default.
- W4361818260 hasOpenAccess W4361818260 @default.
- W4361818260 hasPrimaryLocation W43618182601 @default.
- W4361818260 hasRelatedWork W1921700147 @default.
- W4361818260 hasRelatedWork W1960499469 @default.
- W4361818260 hasRelatedWork W1977241907 @default.
- W4361818260 hasRelatedWork W2011301069 @default.
- W4361818260 hasRelatedWork W2030847636 @default.
- W4361818260 hasRelatedWork W2032845650 @default.
- W4361818260 hasRelatedWork W2165049020 @default.
- W4361818260 hasRelatedWork W2166354880 @default.
- W4361818260 hasRelatedWork W2362572464 @default.
- W4361818260 hasRelatedWork W2409170580 @default.
- W4361818260 isParatext "false" @default.
- W4361818260 isRetracted "false" @default.
- W4361818260 workType "article" @default.